Cartagenia Launches Next-Generation Sequence Analysis Software for Clinical Labs | GenomeWeb

By Uduak Grace Thomas

Cartagenia this week released a version of its Bench Lab software that is geared toward analyzing next-generation sequence data in clinical laboratories.

Leuven, Belgium-based Cartagenia said that its new product, dubbed Bench Lab NGS, focuses on standardizing the process of interpreting data. Prior to launching the software, the company ran a beta test program with about 10 European and US clinical laboratories in order to ensure that it met the needs of that market.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.